Inventor · disambiguated record
Barry Forman
Also filed as: FORMAN BARRY · FORMAN BARRY M · FORMAN BARRY MARC
28 granted patents·17 pending applications·452 citations·filing 1995–2020
97Inventor score
Files withHOPE CITY17SALK INST FOR BIOLOGICAL STUDI14FORMAN BARRY3ALLERGAN SALES INC1CITY OF HOPE NAT MEDICAL CT1
Top patents by PatentIndex Score
45 records- 0191US6458926B1Heterodimer complex of RXR and NURR1 or NGFI-BSALK INST FOR BIOLOGICAL STUDI·Filed 1997·Granted Oct 1, 2002·72 cites·10 claims
- 0290US8119695B2Compounds and methods for treating breast cancer and other diseasesFORMAN BARRY·Filed 2009·Granted Feb 21, 2012·10 cites·7 claims
- 0390US6416957B1Method for modulating process mediated by farnesoid activated receptorsSALK INST FOR BIOLOGICAL STUDI·Filed 2000·Granted Jul 9, 2002·29 cites·24 claims
- 0489US6906057B1Methods for modulating FXR receptor activityCITY OF HOPE NAT MEDICAL CT·Filed 2000·Granted Jun 14, 2005·41 cites·30 claims
- 0588US8993628B2Synthetic ligands selective for LXRβ over LXRα, identification and methods of use thereofFORMAN BARRY·Filed 2008·Granted Mar 31, 2015·7 cites·4 claims
- 0688US7544838B2Ligands for estrogen related receptors and methods for synthesis of said ligandsHOPE CITY·Filed 2006·Granted Jun 9, 2009·6 cites·4 claims
- 0786US5939442AModulations of peroxisome proliferator activated receptor-γ, and methods for the use thereofSALK INST FOR BIOLOGICAL STUDI·Filed 1995·Granted Aug 17, 1999·64 cites·20 claims
- 0884US6413994B1Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2001·Granted Jul 2, 2002·12 cites·19 claims
- 0983US6184353B1Method for modulating processes mediated by farnesoid activated receptorsSALK INST FOR BIOLOGICAL STUDI·Filed 1999·Granted Feb 6, 2001·28 cites·8 claims
- 1082US7531578B2Compounds and methods for treating breast cancer and other diseasesHOPE CITY·Filed 2004·Granted May 12, 2009·10 cites·1 claims
- 1181US6214850B1Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereofSALK INST FOR BIOLOGICAL STUDI·Filed 1999·Granted Apr 10, 2001·39 cites·20 claims
- 1280US6586189B2Screening method for PPAR-γ ligandsHOPE CITY·Filed 2001·Granted Jul 1, 2003·19 cites·3 claims
- 1377US6605627B2Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereofSALK INSITUTE FOR BIOLOG STUDI·Filed 2002·Granted Aug 12, 2003·6 cites·20 claims
- 1477US6005086AFarnesoid activated receptor polypeptides, and nucleic acid encoding the sameSALK INST FOR BIOLOGICAL STUDI·Filed 1995·Granted Dec 21, 1999·33 cites·10 claims
- 1574US9944605B2Farnesoid X receptor antagonistsHOPE CITY·Filed 2016·Granted Apr 17, 2018·1 cites·17 claims
- 1674US6022897ASelective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereofSALK INST FOR BIOLOGICAL STUDI·Filed 1995·Granted Feb 8, 2000·30 cites·15 claims
- 1773US8044241B2Ligands for estrogen related receptors and methods for synthesis of said ligandsHOPE CITY·Filed 2009·Granted Oct 25, 2011·1 cites·5 claims
- 1871US5861274ANucleic acids encoding peroxisome proliferator-activated receptorSALK INST FOR BIOLOGICAL STUDI·Filed 1995·Granted Jan 19, 1999·36 cites·7 claims
- 1968US8338628B2Method of synthesizing alkylated bile acid derivativesYU DONNA D·Filed 2008·Granted Dec 25, 2012·2 cites·4 claims
- 2064US10246481B2Bile acid derivatives and methods for synthesis and useHOPE CITY·Filed 2018·Granted Apr 2, 2019·0 cites·24 claims
- 2164US2020290974A1Farnesoid x receptor antagonistsHOPE CITY·Filed 2020·Application pending·0 cites
- 2262US10611729B2Farnesoid X receptor antagonistsHOPE CITY·Filed 2018·Granted Apr 7, 2020·0 cites·10 claims
- 2360US9085550B2Ligands for estrogen related receptors and methods for synthesis of said ligandsFORMAN BARRY·Filed 2011·Granted Jul 21, 2015·0 cites·2 claims
- 2459US7041498B2Method for modulating processes mediated by farnesoid activated receptorsSALK INST FOR BIOLOGICAL STUDI·Filed 2002·Granted May 9, 2006·1 cites·8 claims
- 2559US6548739B2Method for activating peroxisome proliferator activated receptor-γHOPE CITY·Filed 2001·Granted Apr 15, 2003·2 cites·1 claims
- 2658US2003135873A1Method for activating peroxisome proliferator activated receptor-gammaFiled 2003·Application pending·0 cites
- 2757US7439027B2Method for modulating process mediated by farnesoid activated receptorsSALK INST FOR BIOLOGICAL STUDI·Filed 2006·Granted Oct 21, 2008·0 cites·12 claims
- 2857US2003083469A1Allosteric control of nuclear hormone receptorsSALK INST FOR BIOLOGICAL STUDI·Filed 2002·Application pending·0 cites
- 2957US2017233431A1Bile acid derivatives and methods for synthesis and useHOPE CITY·Filed 2017·Application pending·0 cites
- 3056US2005009837A1Modulators of lipid metabolism and methods of useHOPE CITY·Filed 2004·Application pending·0 cites
- 3154US2005004165A1Composition and method for modulating BAR/FXR receptor activityFiled 2004·Application pending·0 cites
- 3252US2004019027A1Method of treating cerebrotendinous xanthomatosisFiled 2003·Application pending·0 cites
- 3349US2002137663A1The anti-neoplastic agent ET-743 inhibits trans activation by SXRFiled 2001·Application pending·0 cites
- 3448US2005037404A1Methods of modulating drug clearance mechanisms by altering SXR activityHOPE CITY·Filed 2004·Application pending·0 cites
- 3548US2003144360A1Composition and method for modulating BAR/FXR receptor activityALLERGAN SALES INC·Filed 2002·Application pending·0 cites
- 3647US2002022599A1Methods of modulating drug clearance mechanisms by altering SXR activityFiled 2001·Application pending·0 cites
- 3746US2014206657A1Bile acid analog tgr5 agonistsHOPE CITY·Filed 2014·Application pending·0 cites
- 3844US10590056B2ERR modulators and uses thereofHOPE CITY·Filed 2018·Granted Mar 17, 2020·0 cites·29 claims
- 3944US2006154335A1Novel members of the steroid/thyroid superfamily and uses thereforSALK INST FOR BIOLOGICAL STUDI·Filed 2005·Application pending·0 cites
- 4043US10703761B2Bile acid receptor modulators and methods of use thereofHOPE CITY·Filed 2017·Granted Jul 7, 2020·0 cites·11 claims
- 4143US2002132223A1Methods for modulating activity of the FXR nuclear receptorHOPE CITY·Filed 2001·Application pending·0 cites
- 4243US2019077774A1Peroxisome proliferator-activated receptor agonistsHOPE CITY·Filed 2018·Application pending·0 cites
- 4341US6830882B1Method of testing compounds for regulation of transcription of peroxisome proliferator activated receptor—gammaSALK INST FOR BIOLOGICAL STUDI·Filed 1996·Granted Dec 14, 2004·3 cites·12 claims
- 4436US2002061836A1Methods for altering SXR activation using peptide mimetic HIV protease inhibitor SXR ligandsFiled 2001·Application pending·0 cites
- 4535US2007190571A1Detection of an exogenous ligand in biological fluidFORMAN BARRY M·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Barry Forman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →